Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near ...

The pharmaceutical giant Pfizer will to pay a record $2.3 billion settlement for illegal drug promotion. Pfizer Inc. and its subsidiary Pharmacia & Upjohn will pay the settlement to resolve criminal ...

A legal settlement has put wind behind Pfizer’s sales into 2029—at which point key obesity moves will take the helm.

Pfizer reported stronger-than-expected first-quarter results on Tuesday and reaffirmed its full-year guidance, as growth from ...

Pfizer’s first-quarter results gave investors a clearer view of how much work the drugmaker’s newer portfolio is doing as the ...

U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss ...

For the quarter ended March 2026, Pfizer (PFE) reported revenue of $14.45 billion, up 5.4% over the same period last year. EPS came in at $0.75, compared to $0.92 in the year-ago quarter. The reported ...

Pfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC.